RecruitingNCT05785546

Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System

Wheelchair Seating Users With Neuromuscular Diseases: Elaboration of a Pronostic Score of Changes on the Seating System of the Wheelchair


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

368 participants

Start Date

Feb 19, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Development and validation study of a prognostic score - study of prognostic performance by a prospective longitudinal multicenter cohort spread over 8 centers: 4 for the development cohort and 4 for the validation cohort).


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Male or female over the age of 18
  • Daily wheelchair user (more than 4 hours per day)
  • Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II
  • Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team
  • Patient informed and having signed consent.

Exclusion Criteria4

  • Person who already has a seat change or FR prescription at the time of inclusion
  • Having undergone surgery less than 1 year ago or a fracture
  • Pregnant or breastfeeding women
  • Patient under guardianship or curatorship.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERusual care

For each cohort, the patient is seen at least twice, during annual visits in multidisciplinary consultation.


Locations(1)

New technology Platform department, Raymond Poincaré Hospital, APHP

Garches, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05785546


Related Trials